PL328135A1 - Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers - Google Patents

Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Info

Publication number
PL328135A1
PL328135A1 PL97328135A PL32813597A PL328135A1 PL 328135 A1 PL328135 A1 PL 328135A1 PL 97328135 A PL97328135 A PL 97328135A PL 32813597 A PL32813597 A PL 32813597A PL 328135 A1 PL328135 A1 PL 328135A1
Authority
PL
Poland
Prior art keywords
centchromane
enantiomer
preventing
production
application
Prior art date
Application number
PL97328135A
Other languages
English (en)
Inventor
Michael Shalmi
Ved Prakash Kamboj
Omkar Prasad Asthana
Suprabhat Ray
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL328135A1 publication Critical patent/PL328135A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL97328135A 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers PL328135A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
DK77696 1996-07-11
PCT/DK1997/000007 WO1997025034A1 (en) 1996-01-11 1997-01-09 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Publications (1)

Publication Number Publication Date
PL328135A1 true PL328135A1 (en) 1999-01-18

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328135A PL328135A1 (en) 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Country Status (12)

Country Link
EP (1) EP0873119A1 (pt)
JP (1) JP2001500101A (pt)
KR (1) KR19990077157A (pt)
AU (1) AU1367197A (pt)
BR (1) BR9706966A (pt)
CA (1) CA2241462A1 (pt)
CZ (1) CZ217198A3 (pt)
HU (1) HUP9901633A3 (pt)
IL (1) IL124881A0 (pt)
NO (1) NO983177L (pt)
PL (1) PL328135A1 (pt)
WO (1) WO1997025034A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
NZ554619A (en) 2004-10-20 2011-01-28 Endorech Inc Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CN101896174B (zh) 2007-10-16 2012-10-31 利普生物药剂公司 用于治疗代谢综合征的珠氯米芬
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20190042762A (ko) 2010-06-16 2019-04-24 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
MX2014009322A (es) 2012-02-29 2014-11-10 Repros Therapeutics Inc Terapia de combinacion para el tratamiento de la deficiencia androgenica.
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
CN108348605B (zh) 2015-11-10 2023-06-09 帕拉卡林治疗公司 用pdgf-cc抑制剂和抗雌激素治疗er阴性乳癌

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
WO1997025034A1 (en) 1997-07-17
EP0873119A1 (en) 1998-10-28
BR9706966A (pt) 1999-05-04
CA2241462A1 (en) 1997-07-17
HUP9901633A3 (en) 2000-02-28
IL124881A0 (en) 1999-01-26
AU1367197A (en) 1997-08-01
KR19990077157A (ko) 1999-10-25
NO983177L (no) 1998-07-10
CZ217198A3 (cs) 1998-11-11
HUP9901633A2 (hu) 1999-10-28
JP2001500101A (ja) 2001-01-09

Similar Documents

Publication Publication Date Title
EP0718099A3 (de) Präge-Rotationsmaschine
PL323128A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
PL323130A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
EP0973396A4 (en) METHOD FOR TREATING CANCER
GB9801231D0 (en) A method of treating cancer
PL328135A1 (en) Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers
EP0703282A3 (en) Surface treatment composition
GB2325421B (en) Process for coating surgical needles
EP0742849A4 (en) SURFACE TREATMENT AGENT FOR ZINC PLATED STEEL
EP1075533A4 (en) SMALL MOLECULE ANTICANCER COMPOUNDS AND METHODS FOR PRODUCING THE SAME
PL327505A1 (en) Production of biscyclopentadienylodiene complexes
TW458159U (en) Continuous unloading machine
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
GB9614476D0 (en) Rotary machine
CZ71095A3 (en) Track ballastway treating machine
HUP9601972A3 (en) Rotary machine
GB9708204D0 (en) Tablet coating machine
TW348787U (en) Profiled cylinder for teaseling and/or fluffing machines
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
GB2323057B (en) Finishing machine for foil and plate manufacture
CZ72895A3 (en) Track ballastway treating machine
GB2322151B (en) Synthetic surface treatment apparatus
HU9601450D0 (en) Process for producing pharmaceutical composition for treating neoplasmic syndromas
EP1019529A4 (en) METHOD FOR TREATING CANCER
GB9502504D0 (en) Tunnelling machine